For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Semaglutide - Prevention of cardiovascular events
PAD Profile : Semaglutide - Prevention of cardiovascular events
Traffic Light Status
Status 1 of 1.
- Injection
This drug has not yet been assessed for formulary status for the prevention of cardiovascular events.
It has not yet been evaluated by NICE or the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.
Before prescribing this drug/device it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.
NICE have not yet carried out an appraisal but, once published, it will be considered by the APC within 90 days.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
No committee recommendations returned.